Ublituximab: A Fresh Promise for Autoimmune Conditions ?
Ublituximab, a novel antibody , offers a promising development in the approach of immune-driven ailments . Unlike many current therapies, ublituximab selectively targets and depletes B cells, which are a crucial role in the progression of numerous self-attacking illnesses. Early research results